Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG1821

MGRN1 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

MGRN1 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from human Raji B lymphoblastoid cells. This product disrupts the MGRN1 gene, which encodes an E3 ubiquitin ligase controlling endosomal trafficking and melanocortin 1 receptor (MC1R) signaling. MGRN1 ubiquitinates TSG101 and interacts with Hsp70 and ATXN3, linking the ESCRT pathway to receptor degradation and stress responses. In the Raji Burkitt??s lymphoma background, these knockout cells enable investigation of endocytic sorting, ubiquitination, and MC1R surface expression by flow cytometry, co-immunoprecipitation, and endocytosis assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    MGRN1

    Gene Identifier

    NCBI Gene ID 23295

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

MGRN1 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human Raji B lymphoblastoid line, designed to disrupt the MGRN1 gene encoding an E3 ubiquitin ligase. This heterogeneous pool provides a robust loss-of-function model for studying MGRN1-dependent processes in a lymphoid background, enabling investigation of endosomal sorting, ubiquitin-dependent signaling, and melanocortin receptor regulation without clonal selection artifacts.

The Raji host cell line is a classic model of Burkitt??s lymphoma, exhibiting an EBV-positive, male, suspension-growth phenotype. These transformed B lymphocytes are widely used for their rapid proliferation, stable antigen presentation, and active endocytic pathways, making them ideal for exploring oncogenic mechanisms and trafficking processes central to B-cell receptor signaling and immune surveillance.

MGRN1 (Mahogunin Ring Finger 1) is an E3 ubiquitin ligase that regulates the endosomal sorting complex required for transport (ESCRT) pathway and melanocortin 1 receptor (MC1R) signaling. It directly ubiquitinates TSG101, a critical ESCRT-I component, and interacts with Hsp70, Hsp90, ATXN3, and parkin. MGRN1 is activated by heat shock stress and MC1R ligands like ??-MSH, leading to degradation of MC1R and modulation of MITF transcription factor activity. Loss of MGRN1 disrupts endosomal trafficking, receptor turnover, and stress responses, with implications for pigmentation and neurodegeneration.

In Raji B cells, MGRN1 knockout enables dissection of ubiquitin-proteasome and endosomal pathway intersections with lymphocyte functions. B lymphocytes depend on precise endosomal sorting for antigen processing and presentation via MHC class II, as well as B-cell receptor signaling. Disruption of MGRN1 may perturb ESCRT-I-dependent trafficking, altering immune receptor degradation and signaling, thereby providing insights into lymphomagenesis and EBV-driven oncogenesis.

This knockout model supports applications such as co-immunoprecipitation to assess TSG101 and Hsp70 interactions, flow cytometry for MC1R surface expression, and ubiquitination assays. Endocytosis assays with transferrin uptake reveal trafficking defects, while Western blotting and RT-qPCR monitor ESCRT-I subunits and MITF. The cells facilitate studies of melanocortin signaling in lymphoma and chaperone-mediated autophagy. For more information, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)